中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
3期
16-17
,共2页
万爽力%扩张型心肌病%应用研究
萬爽力%擴張型心肌病%應用研究
만상력%확장형심기병%응용연구
Vasorel%Dilated cardiomyopathy%Application Research
目的：探讨万爽力在扩张型心肌病患者中的应用研究。方法：2013年5月-2014年5月收治扩张型心肌病患者88例，随机分为观察组和对照组，每组44例。对照组给予常规药物治疗，观察组在对照组基础上给予万爽力。结果：两组扩张型心肌病患者经过8周的药物治疗后，观察组的总有效率(90.9%)明显高于对照的总有效率(56.8%)。观察组的左心室舒张末期容积的水平明显低于对照组的左心室舒张末期容积的水平；观察组的左心室射血分数与对照组的左心室射血分数相近。对两组扩张型心肌病患者治疗结束后进行定期随访，观察组的急性左心衰竭发作3例，明显少于对照组的急性左心衰竭发作9例。结论：本研究联合分析超声心脏形态学指标、总有效率和定期随访情况，证实曲美他嗪能有效改善扩张型心肌病患者的左心功能，降低心肌病患者病死率，提高患者的生活质量。
目的：探討萬爽力在擴張型心肌病患者中的應用研究。方法：2013年5月-2014年5月收治擴張型心肌病患者88例，隨機分為觀察組和對照組，每組44例。對照組給予常規藥物治療，觀察組在對照組基礎上給予萬爽力。結果：兩組擴張型心肌病患者經過8週的藥物治療後，觀察組的總有效率(90.9%)明顯高于對照的總有效率(56.8%)。觀察組的左心室舒張末期容積的水平明顯低于對照組的左心室舒張末期容積的水平；觀察組的左心室射血分數與對照組的左心室射血分數相近。對兩組擴張型心肌病患者治療結束後進行定期隨訪，觀察組的急性左心衰竭髮作3例，明顯少于對照組的急性左心衰竭髮作9例。結論：本研究聯閤分析超聲心髒形態學指標、總有效率和定期隨訪情況，證實麯美他嗪能有效改善擴張型心肌病患者的左心功能，降低心肌病患者病死率，提高患者的生活質量。
목적：탐토만상력재확장형심기병환자중적응용연구。방법：2013년5월-2014년5월수치확장형심기병환자88례，수궤분위관찰조화대조조，매조44례。대조조급여상규약물치료，관찰조재대조조기출상급여만상력。결과：량조확장형심기병환자경과8주적약물치료후，관찰조적총유효솔(90.9%)명현고우대조적총유효솔(56.8%)。관찰조적좌심실서장말기용적적수평명현저우대조조적좌심실서장말기용적적수평；관찰조적좌심실사혈분수여대조조적좌심실사혈분수상근。대량조확장형심기병환자치료결속후진행정기수방，관찰조적급성좌심쇠갈발작3례，명현소우대조조적급성좌심쇠갈발작9례。결론：본연구연합분석초성심장형태학지표、총유효솔화정기수방정황，증실곡미타진능유효개선확장형심기병환자적좌심공능，강저심기병환자병사솔，제고환자적생활질량。
Objective: To investigate the application of trimetazidine in patients with dilated cardiomyopathy.Methods:88 patients with dilated cardiomyopathy were selected from May 2013 to May 2014.They were randomly divided into the observation group and the control group with 44 cases in each.The control group received routine treatment,and the observation group were given trimetazidine based on the control group.Results:Two groups of patients with dilated cardiomyopathy after 8 weeks drugs treatment,the total efficiency of the observation group(90.9%) was higher than that of the control(56.8%).The left ventricular end diastolic volume of the observation group was significantly lower than that of the control group;the left ventricular ejection fraction of the observation group was similar to that of the control group.We regular follow-up for the end of treatment of two groups of patients with dilated cardiomyopathy,the observation group of patients with acute left heart failure episodes in 3 patients, significantly lower than the control group of 9 cases of patients with acute left heart failure exacerbation.Conclusion:In this study, we combined with analysis of ultrasonic cardiac morphological index,total efficiency and regular follow-up.Confirmed QuMei trimetazidine can improve left ventricular function in patients with dilated cardiomyopathy,reduce the mortality rate of patients with cardiomyopathy,and improve the quality of life of patients.
